These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 37537882)
1. High expression of novel biomarker TBRG4 promotes the progression and invasion of oral squamous cell carcinoma. Ramasubramanian A; Ramani P; Kannan B; Arumugam P J Oral Pathol Med; 2023 Sep; 52(8):738-745. PubMed ID: 37537882 [TBL] [Abstract][Full Text] [Related]
2. High expression of TROP2 is correlated with poor prognosis of oral squamous cell carcinoma. Tang G; Tang Q; Jia L; Xia S; Li J; Chen Y; Li H; Ding X; Wang F; Hou D; Kuai X; Feng Z; Fan Y Pathol Res Pract; 2018 Oct; 214(10):1606-1612. PubMed ID: 30098828 [TBL] [Abstract][Full Text] [Related]
3. Role of hyaluronan mediated motility receptor gene in oral squamous cell carcinoma and clinical prognosis. Tang Y; Xiao Y; Liao R Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Dec; 46(12):1315-1324. PubMed ID: 35232899 [TBL] [Abstract][Full Text] [Related]
4. Increased SEC14L2 expression is associated with clinicopathological features and worse prognosis in oral squamous cell carcinoma. David JJ; Kannan B; Pandi C; Jayaseelan VP; Vasagam JM; Arumugam P Odontology; 2024 Oct; 112(4):1326-1334. PubMed ID: 38575815 [TBL] [Abstract][Full Text] [Related]
5. NCBP2 and TFRC are novel prognostic biomarkers in oral squamous cell carcinoma. Arora R; Haynes L; Kumar M; McNeil R; Ashkani J; Nakoneshny SC; Matthews TW; Chandarana S; Hart RD; Jones SJM; Dort JC; Itani D; Chanda A; Bose P Cancer Gene Ther; 2023 May; 30(5):752-765. PubMed ID: 36635327 [TBL] [Abstract][Full Text] [Related]
6. HMG20A was identified as a key enhancer driver associated with DNA damage repair in oral squamous cell carcinomas. Na L; Meijie Z; Wenjing Z; Bing Z; Yanhao D; Shanshan L; Yongle Q BMC Oral Health; 2022 Nov; 22(1):473. PubMed ID: 36335317 [TBL] [Abstract][Full Text] [Related]
7. Identification and Validation of PLOD2 as an Adverse Prognostic Biomarker for Oral Squamous Cell Carcinoma. Sun Y; Wang S; Zhang X; Wu Z; Li Z; Ding Z; Huang X; Chen S; Jing Y; Zhang X; Ding L; Song Y; Sun G; Ni Y Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944486 [TBL] [Abstract][Full Text] [Related]
8. Prognostic impact of miR-34b/c DNA methylation, gene expression, and promoter polymorphism in HPV-negative oral squamous cell carcinomas. Supic G; Stefik D; Ivkovic N; Sami A; Zeljic K; Jovic S; Kozomara R; Vojvodic D; Stosic S Sci Rep; 2022 Jan; 12(1):1296. PubMed ID: 35079080 [TBL] [Abstract][Full Text] [Related]
9. miR-654-5p Targets GRAP to Promote Proliferation, Metastasis, and Chemoresistance of Oral Squamous Cell Carcinoma Through Ras/MAPK Signaling. Lu M; Wang C; Chen W; Mao C; Wang J DNA Cell Biol; 2018 Apr; 37(4):381-388. PubMed ID: 29364705 [TBL] [Abstract][Full Text] [Related]
10. Macrophage migration inhibitory factor is a novel prognostic marker for human oral squamous cell carcinoma. Kang Y; Zhang Y; Sun Y Pathol Res Pract; 2018 Aug; 214(8):1192-1198. PubMed ID: 30041958 [TBL] [Abstract][Full Text] [Related]
11. Triggering receptor expressed in myeloid cells 1 (TREM1) as a potential prognostic biomarker and association with immune infiltration in oral squamous cell carcinoma. Kannan B; Pandi C; Pandi A; Jayaseelan VP; Arumugam P Arch Oral Biol; 2024 May; 161():105926. PubMed ID: 38442472 [TBL] [Abstract][Full Text] [Related]
12. MiR-455-5p suppresses PDZK1IP1 to promote the motility of oral squamous cell carcinoma and accelerate clinical cancer invasion by regulating partial epithelial-to-mesenchymal transition. Hsiao SY; Weng SM; Hsiao JR; Wu YY; Wu JE; Tung CH; Shen WL; Sun SF; Huang WT; Lin CY; Chen SH; Hong TM; Chen YL; Chang JY J Exp Clin Cancer Res; 2023 Feb; 42(1):40. PubMed ID: 36737832 [TBL] [Abstract][Full Text] [Related]
13. Parathyroid hormone-related protein serves as a prognostic indicator in oral squamous cell carcinoma. Lv Z; Wu X; Cao W; Shen Z; Wang L; Xie F; Zhang J; Ji T; Yan M; Chen W J Exp Clin Cancer Res; 2014 Dec; 33(1):100. PubMed ID: 25539663 [TBL] [Abstract][Full Text] [Related]
14. Decreased CSTA expression promotes lymphatic metastasis and predicts poor survival in oral squamous cell carcinoma. Wang Y; Wang L; Li X; Qu X; Han N; Ruan M; Zhang C Arch Oral Biol; 2021 Jun; 126():105116. PubMed ID: 33831734 [TBL] [Abstract][Full Text] [Related]
15. Identification of Biological Functions and Prognostic Value of NNMT in Oral Squamous Cell Carcinoma. Zhang W; Jing Y; Wang S; Wu Y; Sun Y; Zhuang J; Huang X; Chen S; Zhang X; Song Y; Hu Q; Ni Y Biomolecules; 2022 Oct; 12(10):. PubMed ID: 36291696 [TBL] [Abstract][Full Text] [Related]
16. A Five-mRNA Expression Signature to Predict Survival in Oral Squamous Cell Carcinoma by Integrated Bioinformatic Analyses. Guo H; Li C; Su X; Huang X Genet Test Mol Biomarkers; 2021 Aug; 25(8):517-527. PubMed ID: 34406843 [No Abstract] [Full Text] [Related]
17. The expression and role of tubulin polymerization-promoting protein 3 in oral squamous cell carcinoma. Xiao T; Lin F; Zhou J; Tang Z Arch Oral Biol; 2022 Nov; 143():105519. PubMed ID: 36058091 [TBL] [Abstract][Full Text] [Related]
18. Zinc finger AN1-type containing 4 is a novel marker for predicting metastasis and poor prognosis in oral squamous cell carcinoma. Kurihara-Shimomura M; Sasahira T; Nakamura H; Nakashima C; Kuniyasu H; Kirita T J Clin Pathol; 2018 May; 71(5):436-441. PubMed ID: 29074611 [TBL] [Abstract][Full Text] [Related]
19. New Histopathologic Risk Model for Early T-stage Oral Squamous Cell Carcinoma: Focusing on a Modified Worst Pattern of Invasion System and a New Tumor Budding Score. Chang HY; Hang JF; Kuo YJ Am J Surg Pathol; 2024 Jan; 48(1):59-69. PubMed ID: 37779502 [TBL] [Abstract][Full Text] [Related]
20. FLOT-2 is an independent prognostic marker in oral squamous cell carcinoma. Wen Q; Alnemah MM; Luo J; Wang W; Chu S; Chen L; Li J; Xu L; Li M; Zhou J; Fan S Int J Clin Exp Pathol; 2015; 8(7):8236-43. PubMed ID: 26339392 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]